Webinar: Cytokine adsorption in severely ill COVID-19 patients
- COVID-19, ECMO
The Webinar: Cytokine adsorption in severely ill COVID-19 patients – rationale and clinical experience
Chairs: Prof. John Kellum, Pittsburgh, USA and Prof. Luciano Gattinoni; Göttingen, Germany
- Introduction - Why hemoadsorption seems to be a useful treatment option
John Kellum - Safety and feasibility of CytoSorb therapy in COVID-19 patients – the Wuhan experience
Zhiyong Peng - It is more than just Cytokine removal - the Bergamo and Triest experience
Ivano Riva and Giorgio Berlot - Combination of ECMO and CytoSorb in COVID-19 patients – when and how should we do it
Alexander Supady - We have to collect data to create evidence! CYTOAID - an international multicenter observational trial
Peter Hegyi - Summary
Luciano Gattinoni
Share
|
Webinar: Cytokine adsorption in severely ill COVID-19 patients
Share
|
The Webinar: Cytokine adsorption in severely ill COVID-19 patients – rationale and clinical experience
Chairs: Prof. John Kellum, Pittsburgh, USA and Prof. Luciano Gattinoni; Göttingen, Germany
- Introduction - Why hemoadsorption seems to be a useful treatment option
John Kellum - Safety and feasibility of CytoSorb therapy in COVID-19 patients – the Wuhan experience
Zhiyong Peng - It is more than just Cytokine removal - the Bergamo and Triest experience
Ivano Riva and Giorgio Berlot - Combination of ECMO and CytoSorb in COVID-19 patients – when and how should we do it
Alexander Supady - We have to collect data to create evidence! CYTOAID - an international multicenter observational trial
Peter Hegyi - Summary
Luciano Gattinoni
More Videos
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | CytoSorb therapy in COVID-19 patients